Expression of epithelial-mesenchymal transition-associated proteins and proliferating cell nuclear antigen in dihydropyridine-induced gingival overgrowth fibroblasts: A preliminary study
- PMID: 37021214
- PMCID: PMC10068551
- DOI: 10.1016/j.jds.2022.08.025
Expression of epithelial-mesenchymal transition-associated proteins and proliferating cell nuclear antigen in dihydropyridine-induced gingival overgrowth fibroblasts: A preliminary study
Abstract
Background/purpose: The clinical features of dihydropyridine-induced gingival overgrowth (DIGO), including extracellular matrix accumulation and cell hyperplasia, are regulated by inflammatory factors (e.g., Interleukin-1β [IL-1β]) in combination with calcium channel blockers (e.g., nifedipine [Nif]). We speculated that IL-1β and Nif (IL-1β/Nif) may be the main factor modulating the proliferative potential and turnover of fibroblasts in DIGO.
Materials and methods: We cultured four DIGO fibroblast strains and analysed the possible effects of IL-1β/Nif treatments on epithelial-mesenchymal transition (EMT)-associated proteins. We developed short hairpin ribonucleic acids (shRNAs) and used them to explore the role of IL-1β/Nif in regulating proliferating cell nuclear antigen (PCNA) levels in DIGO tissues.
Results: Our results revealed that compared with control cells, DIGO cells stimulated with IL-1β/Nif had higher levels of the EMT-associated proteins Snail, Slug, and Twist. Moreover, both drugs enhanced androgen receptor (AR), Slug, and PCNA expression.
Conclusion: Taken together, our data indicate that proinflammatory cytokines in combination with calcium channel blockers can regulate the expression of EMT-associated proteins and increase the proliferative potential of DIGO fibroblasts.
Keywords: Dihydropyridine-induced gingival overgrowth; EMT-associated proteins; Interleukin-1β; Nifedipine; PCNA.
© 2022 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier.
Conflict of interest statement
The authors have no conflicts of interest relevant to this article.
Figures





References
-
- Murakami S., Mealey B.L., Mariotti A., Chapple I.L.C. Dental plaque-induced gingival conditions. J Periodontol. 2018;89(Suppl 1):S17–S27. - PubMed
-
- Ellis J.S., Seymour R.A., Steele J.G., Robertson P., Butler T.J., Thomason J.M. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol. 1999;70:63–67. - PubMed
-
- Butler R.T., Kalkwarf K.L., Kaldahl W.B. Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine. J Am Dent Assoc. 1987;114:56–60. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous